Showing results (181-190 of 544) with videos related to
Sort By:
Pageof 55
Leukemia|May 1, 1996
A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemiaS Amadori, A Picardi, P Fazi, et al.British Journal of Haematology|November 1, 1996
Treatment of high-risk myelodysplastic syndromes with lymphoblastoid alpha interferonM C Petti, R Latagliata, G Avvisati, et al.Leukemia Research|January 1, 1984
PHA-ICC, ADCC and NK in patients with ANLL in CR: human fibroblastic interferon fails to increase NK-active cell frequencyL Fontana, G De Rossi, G De Sanctis, et al.Haematologica|December 29, 1998
Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapyG Martinelli, E Ottaviani, N Testoni, et al.Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1985
Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemiaL H Kahle, G Avvisati, R J Lamping, et al.Bollettino Della Societa Italiana Di Biologia Sperimentale|July 30, 1980
Platelet aggregation index assay in the progress of physiological delivery. Preliminary accountM de Siena, G Magri, G Papa, et al.Bone Marrow Transplantation|January 1, 1990
Autologous bone marrow transplantation in patients with AML in first complete remission. Results of two different conditioning regimens after the same induction and consolidation therapyG Meloni, P De Fabritiis, A M Carella, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphomaM Martelli, C Guglielmi, S Coluzzi, et al.Leukemia Research|January 1, 1982
Vindesine in the treatment of refractory hematologic malignancies: a phase II studyF Mandelli, S Amadori, F Giona, et al.Leukemia Research|January 1, 1991
CD9 antigen on acute non-lymphoid leukemia cells: preferential expression by promyelocytic (M3) subtypeD Ferrero, N Carlesso, E Gallo, et al.Pageof 55